{"filing":{"accession_number":"0001193125-26-307792","cik":"0001314102","ticker":"EYPT","company_name":"EyePoint, Inc.","form":"8-K","filing_date":"2026-07-17","report_date":null,"primary_document":"eypt-20260713.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1314102/000119312526307792/eypt-20260713.htm"},"events":[{"id":18672,"run_id":16790,"accession_number":"0001193125-26-307792","anchor_item_number":"1.01","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"summary":"EyePoint settled potential False Claims Act and related civil violations with the DOJ, OIG-HHS, and DHA involving alleged improper sales and marketing practices for DEXYCU® from 2019–2023. The settlement requires payment of $4.68 million plus interest and attorneys' fees, and imposes a five-year Corporate Integrity Agreement with significant compliance obligations. This is a material government settlement resolving regulatory and civil liability exposure.","company_name":"EyePoint, Inc.","ticker":"EYPT","filing_date":"2026-07-17","form":"8-K","submitted_at":null,"items":[{"id":17550,"accession_number":"0001193125-26-307792","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"reasoning":"EyePoint settled potential False Claims Act and related civil violations with the DOJ, OIG-HHS, and DHA involving alleged improper sales and marketing practices for DEXYCU® from 2019–2023. The settlement requires payment of $4.68 million plus interest and attorneys' fees, and imposes a five-year Corporate Integrity Agreement with significant compliance obligations. This is a material government settlement resolving regulatory and civil liability exposure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T20:06:52.271910+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17550,"accession_number":"0001193125-26-307792","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"material_litigation","event_domain":"legal","is_material":true,"confidence":0.92,"reasoning":"EyePoint settled potential False Claims Act and related civil violations with the DOJ, OIG-HHS, and DHA involving alleged improper sales and marketing practices for DEXYCU® from 2019–2023. The settlement requires payment of $4.68 million plus interest and attorneys' fees, and imposes a five-year Corporate Integrity Agreement with significant compliance obligations. This is a material government settlement resolving regulatory and civil liability exposure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T20:06:52.271910+00:00","company_name":"EyePoint, Inc.","ticker":"EYPT","filing_date":"2026-07-17"}]}